财务摘要(报告期)(Chemomab Therapeutics Ltd ADR)
2024年中报 | 2024年一季报 | 2023年年报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
---|---|---|---|---|---|---|---|---|---|
每股指标: | |||||||||
每股收益EPS基本(元) | -0.03 | -0.01 | -0.10 | -0.08 | -0.04 | -0.12 | -0.09 | -0.05 | -0.02 |
每股净资产(元) | 0.70 | 0.94 | 1.20 | 1.86 | 2.53 | 3.28 | 3.90 | 4.53 | 5.02 |
每股经营现金净流量(元) | -0.50 | - | -1.66 | -1.24 | -0.65 | -1.84 | -1.28 | -0.82 | -0.33 |
每股现金流量净额(元) | -0.30 | - | -0.30 | -0.27 | 0.66 | -0.15 | -0.39 | -0.46 | -0.12 |
盈利能力: | |||||||||
净资产收益率平均(%) | -55.59 | -25.51 | -91.02 | -57.45 | -27.28 | -56.60 | -36.52 | -19.94 | -8.60 |
总资产净利率(%) | -40.87 | -19.26 | -74.28 | -46.51 | -22.42 | -51.47 | -33.82 | -18.71 | -8.15 |
投入资本回报率ROIC(%) | -67.05 | -29.52 | -114.24 | -69.66 | -39.98 | -70.25 | -43.71 | -23.61 | -10.60 |
收益质量: | |||||||||
营业利润/利润总额(%) | 104.23 | 104.65 | 105.11 | 103.46 | 103.63 | 101.25 | 99.86 | 97.77 | 104.23 |
资本结构: | |||||||||
资产负债率(%) | 31.35 | 25.98 | 23.27 | 23.77 | 20.16 | 15.88 | 11.14 | 8.06 | 6.10 |
权益乘数 | 1.46 | 1.35 | 1.30 | 1.31 | 1.25 | 1.19 | 1.13 | 1.09 | 1.06 |
产权比率 | 0.46 | 0.35 | 0.30 | 0.31 | 0.25 | 0.19 | 0.13 | 0.09 | 0.06 |
流动资产/总资产(%) | 92.51 | 93.49 | 94.34 | 96.03 | 96.47 | 96.92 | 97.03 | 97.25 | 97.35 |
非流动资产/总资产(%) | 7.49 | 6.51 | 5.66 | 3.97 | 3.53 | 3.08 | 2.97 | 2.75 | 2.65 |
流动负债/负债合计(%) | 94.49 | 94.01 | 93.87 | 99.52 | 99.12 | 98.67 | 97.89 | 96.74 | 94.54 |
非流动负债/负债合计(%) | 5.51 | 5.99 | 6.13 | 0.48 | 0.88 | 1.33 | 2.11 | 3.26 | 5.46 |
归属母公司股东的权益/投入资本(%) | 105.02 | 99.90 | 132.18 | 119.08 | 196.20 | 122.61 | 113.04 | 111.49 | 121.45 |
偿债能力: | |||||||||
流动比率 | 3.12 | 3.83 | 4.32 | 4.06 | 4.83 | 6.18 | 8.90 | 12.48 | 16.87 |
速动比率 | 3.12 | 3.83 | 4.32 | 4.06 | 4.83 | 6.18 | 8.90 | 12.48 | 16.87 |
货币资金/流动负债(%) | 116.90 | 106.07 | 192.06 | 152.12 | 296.77 | 200.31 | 196.11 | 224.92 | 393.15 |
营业利润/流动负债(%) | -181.43 | -92.04 | -526.23 | -252.66 | -129.33 | -422.77 | -363.17 | -263.40 | -151.27 |
经营活动产生的现金流量净额/流动负债(%) | -166.92 | - | -488.03 | -214.97 | -102.70 | -301.82 | -267.79 | -214.20 | -105.52 |
归属母公司股东的权益/负债合计(%) | 219.02 | 284.97 | 329.78 | 320.66 | 396.01 | 529.58 | 797.57 | 1,141.26 | 1,538.60 |
经营活动产生的现金流量净额/负债合计(%) | -157.73 | - | -458.11 | -213.94 | -101.80 | -297.81 | -262.14 | -207.22 | -99.76 |
营业利润/负债合计(%) | -171.44 | -86.53 | -493.97 | -251.44 | -128.19 | -417.15 | -355.51 | -254.82 | -143.01 |
成长能力: | |||||||||
总资产同比增长率(%) | -49.59 | -48.56 | -48.56 | -48.83 | -42.56 | -33.08 | -25.54 | -20.05 | 1.39 |
每股净资产同比增长率(%) | -62.62 | -62.94 | -63.50 | -58.97 | -49.59 | -39.18 | -32.20 | -24.04 | -2.67 |
总负债同比增长率(%) | -33.52 | -33.73 | -24.65 | 50.99 | 89.76 | 136.92 | 190.20 | 83.22 | -24.98 |
基本每股收益同比增长率(%) | 65.79 | 65.00 | 14.88 | -52.00 | -81.82 | -101.67 | -123.68 | -108.33 | -100.00 |
归属母公司股东的权益同比增长率(%) | -54.60 | -52.31 | -53.08 | -57.58 | -51.16 | -41.07 | -31.88 | -23.81 | 3.76 |
营业利润同比增长率(%) | 54.67 | 55.27 | 10.77 | -48.99 | -70.09 | -130.72 | -170.88 | -159.97 | -213.13 |
股东权益合计同比增长率(%) | -54.60 | -52.31 | -53.08 | -57.58 | -51.16 | -41.07 | -31.88 | -23.81 | 3.76 |
营运能力: | |||||||||
衍生指标: | |||||||||
现金及现金等价物净增加额TTM(元) | -5,346,000.00 | -4,228,000.00 | -4,228,000.00 | 496,000.00 | 6,930,000.00 | -1,645,000.00 | -26,979,000.00 | -35,489,000.00 | -44,319,000.00 |
利润总额TTM(元) | -15,052,000.00 | -19,357,000.00 | -24,221,000.00 | -33,010,000.00 | -31,808,000.00 | -28,180,000.00 | -24,954,000.00 | -19,842,000.00 | -15,878,000.00 |
投入资本(元) | 9,508,000.00 | 13,344,000.00 | 12,859,000.00 | 18,467,000.00 | 14,248,000.00 | 29,544,000.00 | 39,478,000.00 | 46,495,000.00 | 47,129,000.00 |
经营活动产生的现金流量净额TTM(元) | -16,130,000.00 | -23,611,000.00 | -23,611,000.00 | -25,630,000.00 | -23,845,000.00 | -20,370,000.00 | -17,561,000.00 | -14,886,000.00 | -14,792,000.00 |
归属母公司净利润TTM(元) | -14,997,000.00 | -19,336,000.00 | -24,221,000.00 | -33,075,000.00 | -31,295,000.00 | -27,646,000.00 | -24,410,000.00 | -19,298,000.00 | -15,878,000.00 |
所得税TTM(元) | - | - | - | 65,000.00 | -534,000.00 | -534,000.00 | - | - | - |